JMJ Fintech Rights Issue 2025 vs Kilitch Drugs (india) Rights Issue 2025

Comparison between JMJ Fintech Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for JMJ Fintech Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025. JMJ Fintech Rights Issue 2025 is listed on BSE while Kilitch Drugs (india) Rights Issue 2025 is listed on BSE, NSE.

 JMJ Fintech LimitedKilitch Drugs (india) Ltd.
LogoJMJ Fintech Rights Issue 2025 LogoKilitch Drugs (india) Rights Issue 2025 Logo
Listing AtBSEBSE, NSE
Terms of Payment

Issue Price of Rs. 10.50 per share is payable as Rs. 3.15 per share on Application and Rs.7.35 per share on First and Final Call.

The full amount of the Issue Price Rs 357/- will be payable on application.

Entitlement2 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date2 Rights Equity Share(s) for every 23 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarPurva Sharegistry (India) Pvt.Ltd.MUFG Intime India Pvt.Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of JMJ Fintech Rights Issue 2025 rights issue is ₹26.88 Crores, whereas Kilitch Drugs (india) Rights Issue 2025 rights issue size is ₹49.93 Crores.

 JMJ Fintech LimitedKilitch Drugs (india) Ltd.
Issue Size2,56,00,000 shares13,98,463 shares
Issue Size (Amount)₹26.88 Crores₹49.93 Crores
Issue Price₹10.5 per share₹357 per share
Face Value₹10 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of JMJ Fintech Rights Issue 2025 is Jul 11, 2025 while record date of Kilitch Drugs (india) Rights Issue 2025 is Jul 15, 2025.

 JMJ Fintech LimitedKilitch Drugs (india) Ltd.
Record DateJul 11, 2025Jul 15, 2025
Credit of Rights EntitlementsJul 16, 2025Jul 16, 2025
Bid/Offer Opens OnJul 18, 2025Jul 23, 2025
Renunciation of Rights EntitlementsAug 11, 2025Aug 18, 2025
Bid/Offer Closes OnAug 14, 2025Aug 21, 2025
Deemed Date of AllotmentAug 20, 2025Aug 22, 2025
Credit DateAug 28, 2025Aug 26, 2025
Listing DateSep 01, 2025Aug 28, 2025

Financials details

Comparison of JMJ Fintech Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 JMJ Fintech LimitedKilitch Drugs (india) Ltd.
Financial

JMJ Fintech Limited Financial Information (Restated Standalone)

JMJ Fintech Limited's revenue increased by 130% and profit after tax (PAT) rose by 142% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Assets48.0527.45
Revenue17.157.47
Profit After Tax5.172.14
EBITDA11.244.89
Net Worth23.6315.57
Total Borrowing21.0710.36
Amount in ₹ Crore

Kilitch Drugs (india) Ltd. Financial Information (Restated Consolidated)

Kilitch Drugs (india) Ltd.'s revenue increased by 28% and profit after tax (PAT) rose by 84% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Revenue198.32154.37
Profit After Tax24.9413.58
Net Worth202.33176.29
Reserves and Surplus186.25160.21
Amount in ₹ Crore

Compare with others

Compare: